Ted Love

Ted Love

Directeur/Bestuurslid bij LISATA THERAPEUTICS, INC.

Vermogen: 5 M $ op 31-08-2026

67 jaar
Health Technology
Commercial Services
Consumer Services

Profiel

Dr. Ted W.
Love
, MD, is an Independent Director at Jazz Pharmaceuticals Plc, an Independent Director at Gilead Sciences, Inc., an Independent Director at Structure Therapeutics, Inc. and a Lead Independent Director at Royalty Pharma Plc.
He is on the Board of Directors at Lisata Therapeutics, Inc., Jazz Pharmaceuticals Plc, Gilead Sciences, Inc., Structure Therapeutics, Inc., Royalty Pharma Plc, Avillion LLP, Biotechnology Innovation Organization and Life Science Cares Bay Area.
Dr. Love was previously employed as a Chairman by Marea Therapeutics, Inc., an Independent Director by Seagen, Inc., an Independent Director by Portola Pharmaceuticals LLC, a President, Chief Executive Officer & Director by Global Blood Therapeutics, Inc., an Independent Director by CASCADIAN THERAPEUTICS INC, an Independent Director by Mast Therapeutics, Inc., an Independent Director by Amicus Therapeutics, Inc., an Independent Director by Bio-Rad Laboratories, Inc., an Executive VP, Head-Research & Development by Onyx Pharmaceuticals, Inc., a Lead Independent Director by KaloBios Pharmaceuticals, Inc., an Independent Director by Affymax, Inc., an Independent Director by Santarus, Inc., a Chairman, President & Chief Executive Officer by Nuvelo, Inc., a Senior Vice President-Development by Theravance, Inc., a Senior Vice President-Development by Theravance Biopharma Us LLC, and a VP-Product Development & Regulatory Affairs by Genentech, Inc. He also served on the board at Anesiva, Inc., ARCA biopharma, Inc., California Institute for Regenerative Medicine, ARCA biopharma, Inc. /Old/, California Healthcare Institute, Predix Pharmaceuticals, Inc., Stanford Health Care-Stanford Hospital and The Biotechnology Institute.
He received his undergraduate degree from Haverford College and a doctorate degree from Yale School of Medicine.

Bekende belangen in openbare bedrijven

OndernemingDatumAantal aandelenTotale waardeWaarderingsdatum
05-06-2026 58.393 ( 0,01% ) 4 M $ 31-08-2026
30-04-2026 5.484 ( 0% ) 802 529 $ 31-08-2026
31-08-2026 2.389 ( 0% ) 598 875 $ 31-08-2026
17-06-2026 0 ( -.--% ) - $ 31-08-2026

Actieve functies van Ted Love

BedrijvenFunctieBegin
ROYALTY PHARMA PLC Directeur/Bestuurslid 30-07-2020
LISATA THERAPEUTICS, INC. Directeur/Bestuurslid 17-09-2026
JAZZ PHARMACEUTICALS PLC Directeur/Bestuurslid 01-12-2025
GILEAD SCIENCES, INC. Directeur/Bestuurslid 01-02-2024
STRUCTURE THERAPEUTICS INC. Directeur/Bestuurslid 03-08-2023
Directeur/Bestuurslid 22-07-2013
Directeur/Bestuurslid 01-01-2025
Life Science Cares Bay Area
Directeur/Bestuurslid -

Eerdere bekende functies van Ted Love

BedrijvenFunctieEinde
SEAGEN INC. Directeur/Bestuurslid 14-12-2023
░░░░░░ ░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
Ervaring van Ted Love in detail bekijken

Opleiding van Ted Love

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Connecties

66

Eerstegraads connecties

33

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Verwante bedrijven

Bedrijven in privébezit33

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Consumer Services

Health Services

Health Technology

Government

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Consumer Services

Health Technology

Health Technology

Life Science Cares Bay Area

Commercial Services

Health Technology